IL17A and type 1 diabetes mellitus: In this context, Stojanović et al., 2017, demonstrated that PEx alleviated symptoms of type 1 diabetes, by inhibiting the infiltration of immune cell into pancreatic islets and decreasing IL-17 and IFN-γ production in gut-associated lymphoid tissue in vivo and in vitro [45].